Literature DB >> 8014193

Cell cycle control and cancer chemotherapy.

K W Kohn1, J Jackman, P M O'Connor.   

Abstract

As detailed information accumulates about how cell cycle events are regulated, we can expect new opportunities for application to cancer therapy. The altered expression of oncogenes and tumor suppressor genes that commonly occurs in human cancers may impair the ability of the cells to respond to metabolic perturbations of stress. Impaired cell cycle regulation would make cells vulnerable to pharmacologic intervention by drug regimens tailored to the defects existing in particular tumors. Recent findings that may become applicable to therapy are reviewed, and the possible form of new therapeutic stratagems is considered.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014193     DOI: 10.1002/jcb.240540411

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  15 in total

1.  Increased vulnerability of newly forming beta cells to cytokine-induced cell death.

Authors:  J J Meier; R A Ritzel; K Maedler; T Gurlo; P C Butler
Journal:  Diabetologia       Date:  2005-12-02       Impact factor: 10.122

2.  Association of p53 and WAF1 expression with apoptosis in diffuse alveolar damage.

Authors:  D Guinee; M Fleming; T Hayashi; M Woodward; J Zhang; J Walls; M Koss; V Ferrans; W Travis
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

3.  Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest.

Authors:  X Wang; C H McGowan; M Zhao; L He; J S Downey; C Fearns; Y Wang; S Huang; J Han
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

4.  ADP-ribosylarginine hydrolase regulates cell proliferation and tumorigenesis.

Authors:  Jiro Kato; Jianfeng Zhu; Chengyu Liu; Mario Stylianou; Victoria Hoffmann; Martin J Lizak; Connie G Glasgow; Joel Moss
Journal:  Cancer Res       Date:  2011-06-22       Impact factor: 12.701

5.  Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells.

Authors:  S A Stewart; B Poon; J B Jowett; Y Xie; I S Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

6.  Single-cell RNA-seq recognized the initiator of epithelial ovarian cancer recurrence.

Authors:  Tongtong Kan; Shupeng Zhang; Shengtao Zhou; Ya Zhang; Yun Zhao; Yinghua Gao; Tao Zhang; Feng Gao; Xin Wang; Linjie Zhao; Mengsu Yang
Journal:  Oncogene       Date:  2022-01-07       Impact factor: 9.867

Review 7.  DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis.

Authors:  Estelle Schmitt; Claudie Paquet; Myriam Beauchemin; Richard Bertrand
Journal:  J Zhejiang Univ Sci B       Date:  2007-06       Impact factor: 3.066

8.  Suppression of annexin A11 in ovarian cancer: implications in chemoresistance.

Authors:  Jin Song; Ie-ming Shih; Daniel W Chan; Zhen Zhang
Journal:  Neoplasia       Date:  2009-06       Impact factor: 5.715

9.  Cdk2 and Cdk4 activities are dispensable for tumorigenesis caused by the loss of p53.

Authors:  V C Padmakumar; Eiman Aleem; Cyril Berthet; Mary Beth Hilton; Philipp Kaldis
Journal:  Mol Cell Biol       Date:  2009-03-23       Impact factor: 4.272

10.  Protein expression profiles indicative for drug resistance of non-small cell lung cancer.

Authors:  M Volm; R Koomägi; J Mattern; T Efferth
Journal:  Br J Cancer       Date:  2002-07-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.